ClinicalTrials.gov
public full text
Public Domain
Emicizumab in Patients With Acquired Hemophilia A
This is a phase II multicenter open-label, single-arm prospective study to evaluate the efficacy of prophylactic emicizumab administered on a scheduled basis to prevent bleeds in patients with acquired hemophilia A (AHA).
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- An Expanded Access Program of Emicizumab in Participants With Hemophilia A With Inhibitors#28479
- Emicizumab and shared medical decision in patients living with hemophilia A.#923640
- Outcomes of Prophylaxis With Emicizumab in Children With Severe Hemophilia A in Ivory Coast#1127999
- Use of a TGA and TEM in the Assessment of the Efficacy of Treatment With APCC or rFVIIa#909573
- UPLC-MS/MS Monitoring of Emicizumab Therapy#979459
Record · ID 915496
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive